What about Plaintiff Lawyer Advertising? | Drug & Device Law
As we’ve discussed earlier several times, there is a lot of lawyer advertising on television and in other media, and it can have adverse effects. A| Drug & Device Law
As we’ve discussed earlier several times, there is a lot of lawyer advertising on television and in other media, and it can have adverse effects. A| Drug & Device Law
With apologies to Harry Kalas. Bexis had a couple of encounters with the “Wayback Machine” (a/k/a/ the “Internet Archive”) recently. If you don’t know| Drug & Device Law
For over fifty years, the BBC has been chronicling the exploits of that ultimate learned intermediary, Dr. Who. Over the decades, successive Doctors have| Drug & Device Law
As we have riffed on before, staying apolitical when discussing the science and law implicated by our posts can be harder than one might expect.| Drug & Device Law
Late last year, we discussed the dismissal of three purported California no-injury class actions alleging that certain over the counter (“OTC”) acne| Drug & Device Law
It might seem that we talk about preemption incessantly on this blog, but a pretty good opinion from a pretty important jurisdiction went unremarked by us| Drug & Device Law
A federal judge in California filed an important OTC preemption decision earlier this month, and it’s important because it applied federal preemption to| Drug & Device Law
An appellate court in Texas filed an opinion last week that very helpfully defines and applies the standard for specific personal jurisdiction under a| Drug & Device Law
This publication offers insight and commentary regarding the defense of pharmaceutical and medical device product liability litigation.| Drug & Device Law
From a doctrinal standpoint, courts rely on a well-established principle: experts are permitted to testify to assist the fact-finder, not| Drug & Device Law
Bexis has been updating the preemption chapter of his treatise on drug/device product liability litigation. He came across several preemption| Drug & Device Law
Stephen McConnell| Drug & Device Law
Steven Boranian| Drug & Device Law
The plaintiff in Kane v. Covidien LP, 2025 U.S. Dist. Lexis 25718 (E.D.N.Y. Feb. 12, 2025), lost the bulk of her case recently, on a motion to dismiss no| Drug & Device Law
In our first-on-the-web quickie analysis of United States v. Caronia, ___ F.3d ___, 2012 WL 5992141 (2d Cir. Dec. 3, 2012), we didn’t have time to do much| Drug & Device Law
In 2018, our blogpost on In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices & Liability Litigation, 903 F.3d 278 (3d Cir.| Drug & Device Law
Michelle Yeary| Drug & Device Law
Researchers at Temple University here in Philly recently published a scientific article, “Learning Impairments, Memory Deficits, and Neuropathology in| Drug & Device Law
In addition to its recent revamp of its “§510(k)” substantial equivalence clearance process for medical devices, (see our post here), the FDA has also| Drug & Device Law
